Chapter 12 Serine Kinases of Insulin Receptor Substrate Proteins

Vitamins and Hormones

Volumn 80, Issue C, 2009, Pages 313-349

  Boura Halfon, Sigalit ^a   Zick, Yehiel ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

IGF 1; Insulin; Insulin receptor substrate proteins; Insulin resistance; Ser Thr phosphorylation

Indexed keywords

INSULIN; INSULIN RECEPTOR SUBSTRATE; PROTEIN SERINE THREONINE KINASE;

CHEMISTRY; DIABETES MELLITUS; HUMAN; METABOLISM; REVIEW;

DIABETES MELLITUS; HUMANS; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; PROTEIN-SERINE-THREONINE KINASES;

EID: 61349200310     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0083-6729(08)00612-2     Document Type: Review

References (202)

1. Adam-Klages S., Adam D., Wiegmann K., Struve S., Kolanus W., Schneider M.J., and Kronke M. Fan, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase. Cell 86 (1996) 937-947
2. Aguirre V., Uchida T., Yenush L., Davis R., and White M.F. c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J. Biol. Chem. 275 (2000) 9047-9054
3. Aguirre V., Werner E.D., Giraud J., Lee Y.H., Shoelson S.E., and White M.F. Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J. Biol. Chem. 277 (2002) 1531-1537
4. Anderwald C., and Roden M. Adipotoxicity and the insulin resistance syndrome. Pediatr. Endocrinol. Rev. 1 (2004) 310-319
5. Araki E., Lipes M.A., Patti M.E., Bruning J.C., Haag B., Johnson R.S., and Kahn C.R. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372 (1994) 186-190
6. Argiles J.M., Lopez-Soriano J., Almendro V., Busquets S., and Lopez-Soriano F.J. Cross-talk between skeletal muscle and adipose tissue: A link with obesity?. Med. Res. Rev. 25 (2005) 49-65
7. Arkan M.C., Hevener A.L., Greten F.R., Maeda S., Li Z.W., Long J.M., Wynshaw-Boris A., Poli G., Olefsky J., and Karin M. IKK-beta links inflammation to obesity-induced insulin resistance. Nat. Med. 11 (2005) 191-198
8. Austin R.L., Rune A., Bouzakri K., Zierath J.R., and Krook A. siRNA-mediated reduction of inhibitor of nuclear factor-kappaB kinase prevents tumor necrosis factor-alpha-induced insulin resistance in human skeletal muscle. Diabetes 57 (2008) 2066-2073
9. Avruch J., Hara K., Lin Y., Liu M., Long X., Ortiz-Vega S., and Yonezawa K. Insulin and amino-acid regulation of mTOR signaling and kinase activity through the Rheb GTPase. Oncogene 25 (2006) 6361-6372
10. Bandyopadhyay G., Standaert M.L., Zhao L., Yu B., Avignon A., Galloway L., Karnam P., Moscat J., and Farese R.V. Activation of protein kinase C (alpha, beta, and zeta) by insulin in 3T3/L1 cells. Transfection studies suggest a role for PKC-zeta in glucose transport. J. Biol. Chem. 272 (1997) 2551-2558
11. Bandyopadhyay G., Sajan M.P., Kanoh Y., Standaert M.L., Quon M.J., Lea-Currie R., Sen A., and Farese R.V. PKC-zeta mediates insulin effects on glucose transport in cultured preadipocyte-derived human adipocytes. J. Clin. Endocrinol. Metab. 87 (2002) 716-723
12. Baserga R. The IGF-I receptor in cancer research. Exp. Cell Res. 253 (1999) 1-6
13. Beitner J.D., Blakesley V.A., Shen O.Z., Jimenez M., Stannard B., Wang L.M., Pierce J., and LeRoith D. The proto-oncogene product c-Crk associates with insulin receptor substrate-1 and 4PS. Modulation by insulin growth factor-I (IGF) and enhanced IGF-I signaling. J. Biol. Chem. 271 (1996) 9287-9290
14. Bitar M.S., and Labbad Z.N. Transforming growth factor-beta and insulin-like growth factor-I in relation to diabetes-induced impairment of wound healing. J. Surg. Res. 61 (1996) 113-119
15. Boden G., and Shulman G.I. Free fatty acids in obesity and type 2 diabetes: Defining their role in the development of insulin resistance and beta-cell dysfunction. Eur. J. Clin. Invest. 32 Suppl. 3 (2002) 14-23
16. Boura-Halfon S., and Zick Y. Phosphorylation of IRS proteins, insulin action and insulin resistance. Am. J. Physiol. (2008) (in press)
17. Boura-Halfon S., Beck A., Petrovich K., Gurevitch D., Sasson K., Ronen D., and Zick Y. A novel domain mediates ubiquitination-independent, insulin-induced proteasomal degradation of IRS-1. Third Ruseell Berrie D-Cure Symposium (Abstract Book, 2007) (2008) 59
18. Bouzakri K., Roques M., Gual P., Espinosa S., Guebre-Egziabher F., Riou J.P., Laville M., Le Marchand-Brustel Y., Tanti J.F., and Vidal H. Reduced activation of phosphatidylinositol-3 kinase and increased serine 636 phosphorylation of insulin receptor substrate-1 in primary culture of skeletal muscle cells from patients with type 2 diabetes. Diabetes 52 (2003) 1319-1325
19. Braiman L., Alt A., Kuroki T., Ohba M., Bak A., Tennenbaum T., and Sampson S.R. Activation of protein kinase C zeta induces serine phosphorylation of VAMP2 in the GLUT4 compartment and increases glucose transport in skeletal muscle. Mol. Cell. Biol. 21 (2001) 7852-7861
20. Butler A.A., Yakar S., Gewolb I.H., Karas M., Okubo Y., and LeRoith D. Insulin-like growth factor-I receptor signal transduction: At the interface between physiology and cell biology. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 121 (1998) 19-26
21. Cai D., Yuan M., Frantz D.F., Melendez P.A., Hansen L., Lee J., and Shoelson S.E. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat. Med. 11 (2005) 183-190
22. Cantley L.C. The phosphoinositide 3-kinase pathway. Science 296 (2002) 1655-1657
23. Capecchi M.R. Altering the genome by homologous recombination. Science 244 (1989) 1288-1292
24. Carriere A., Cargnello M., Julien L.A., Gao H., Bonneil E., Thibault P., and Roux P.P. Oncogenic MAPK signaling stimulates mTORC1 activity by promoting RSK-mediated raptor phosphorylation. Curr. Biol. 18 (2008) 1269-1277
25. Ciaraldi T.P., Nikoulina S.E., Bandukwala R.A., Carter L., and Henry R.R. Role of glycogen synthase kinase-3 alpha in insulin action in cultured human skeletal muscle cells. Endocrinology 148 (2007) 4393-4399
26. Cohen P., and Frame S. The renaissance of GSK3. Nat. Rev. Mol. Cell Biol. 2 (2001) 769-776
27. Craparo A., Freund R., and Gustafson T.A. 14-3-3 (epsilon) interacts with the insulin-like growth factor I receptor and insulin receptor substrate I in a phosphoserine-dependent manner. J. Biol. Chem. 272 (1997) 11663-11669
28. Cross D.A., Alessi D.R., Cohen P., Andjelkovich M., and Hemmings B.A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378 (1995) 785-789
29. Datta S.R., Dudek H., Tao X., Masters S., Fu H., Gotoh Y., and Greenberg M.E. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91 (1997) 231-241
30. Davis R.J. Signal transduction by the JNK group of MAP kinases. Cell 103 (2000) 239-252
31. de Alvaro C., Teruel T., Hernandez R., and Lorenzo M. Tumor necrosis factor alpha produces insulin resistance in skeletal muscle by activation of inhibitor kappaB kinase in a p38 MAPK-dependent manner. J. Biol. Chem. 279 (2004) 17070-17078
32. De Fea K., and Roth R.A. Modulation of insulin receptor substrate-1 tyrosine phosphorylation and function by mitogen-activated protein kinase. J. Biol. Chem. 272 (1997) 31400-31406
33. de Luca C., and Olefsky J.M. Inflammation and insulin resistance. FEBS Lett. 582 (2008) 97-105
34. del Peso L., Gonzalez-Garcia M., Page C., Herrera R., and Nunez G. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278 (1997) 687-689
35. Draznin B. Molecular mechanisms of insulin resistance: Serine phosphorylation of insulin receptor substrate-1 and increased expression of p85alpha: The two sides of a coin. Diabetes 55 (2006) 2392-2397
36. Du J., Chen Q., Takemori H., and Xu H. SIK2 can be activated by deprivation of nutrition and it inhibits expression of lipogenic genes in adipocytes. Obesity (Silver Spring) 16 (2008) 531-538
37. Ebina Y., Ellis L., Jarnagin K., Edery M., Graf L., Clauser E., Ou J.H., Masiarz F., Kan Y., Goldfine I.D., Roth R.A., and Rutter W.J. The human insulin receptor cDNA: The structural basis for hormone-activated transmembrane signalling. Cell 40 (1985) 747-758
38. Eck M.J., Dhe P.S., Trub T., Nolte R.T., and Shoelson S.E. Structure of the IRS-1 PTB domain bound to the juxtamembrane region of the insulin receptor. Cell 85 (1996) 695-705
39. Egawa K., Nakashima N., Sharma P.M., Maegawa H., Nagai Y., Kashiwagi A., Kikkawa R., and Olefsky J.M. Persistent activation of phosphatidylinositol 3-kinase causes insulin resistance due to accelerated insulin-induced insulin receptor substrate-1 degradation in 3T3-L1 adipocytes. Endocrinology 141 (2000) 1930-1935
40. Eldar-Finkelman H., and Krebs E.G. Phosphorylation of insulin receptor substrate 1 by glycogen synthase kinase 3 impairs insulin action. Proc. Natl. Acad. Sci. USA 94 (1997) 9660-9664
41. Eldar-Finkelman H., Schreyer S.A., Shinohara M.M., LeBoeuf R.C., and Krebs E.G. Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice. Diabetes 48 (1999) 1662-1666
42. Emanuelli B., Peraldi P., Filloux C., Chavey C., Freidinger K., Hilton D.J., Hotamisligil G.S., and Van Obberghen E. SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-alpha in the adipose tissue of obese mice. J. Biol. Chem. 276 (2001) 47944-47949
43. Fain J.N., Madan A.K., Hiler M.L., Cheema P., and Bahouth S.W. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 145 (2004) 2273-2282
44. Farese R.V., Sajan M.P., Yang H., Li P., Mastorides S., Gower W.R.J., Nimal S., Choi C.S., Kim S., Shulman G.I., Kahn C.R., and Braun U.M.L. Muscle-specific knockout of PKC-lambda impairs glucose transport and induces metabolic and diabetic syndromes. J. Clin. Invest. 117 (2007) 2289-2301
45. Farhang-Fallah J., Yin X., Trentin G., Cheng A.M., and Rozakis-Adcock M. Cloning and characterization of PHIP, a novel insulin receptor substrate-1 pleckstrin homology domain interacting protein. J. Biol. Chem. 275 (2000) 40492-40497
46. Farhang-Fallah J., Randhawa V.K., Nimnual A., Klip A., Bar-Sagi D., and Rozakis-Adcock M. The pleckstrin homology (PH) domain-interacting protein couples the insulin receptor substrate 1 PH domain to insulin signaling pathways leading to mitogenesis and GLUT4 translocation. Mol. Cell. Biol. 22 (2002) 7325-7336
47. Feng Z., Hu W., de Stanchina E., Teresky A.K., Jin S., Lowe S., and Levine A.J. The regulation of AMPK beta1, TSC2, and PTEN expression by p53: Stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways. Cancer Res. 67 (2007) 3043-3053
48. Fingar D.C., and Blenis J. Target of rapamycin (TOR): An integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene 23 (2004) 3151-3171
49. Fraenkel M., Ketzinel-Gilad M., Ariav Y., Pappo O., Karaca M., Castel J., Berthault M.F., Magnan C., Cerasi E., Kaiser N., and Leibowitz G. mTOR inhibition by rapamycin prevents beta-cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetes. Diabetes 57 (2008) 945-957
50. Freude S., Leeser U., Muller M., Hettich M.M., Udelhoven M., Schilbach K., Tobe K., Kadowaki T., Kohler C., Schroder H., Krone W., Bruning J.C., et al. IRS-2 branch of IGF-1 receptor signaling is essential for appropriate timing of myelination. J. Neurochem 107 (2008) 907-917
51. Frye R.A. Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem. Biophys. Res. Commun. 273 (2000) 793-798
52. Gao Z., Hwang D., Bataille F., Lefevre M., York D., Quon M.J., and Ye J. Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex. J. Biol. Chem. 277 (2002) 48115-48121
53. Giraud J., Leshan R., Lee Y.H., and White M.F. Nutrient-dependent and insulin-stimulated phosphorylation of insulin receptor substrate-1 on serine 302 correlates with increased insulin signaling. J. Biol. Chem. 279 (2004) 3447-3454
54. Giraud J., Haas M., Feener E.P., Copps K.D., Dong X., Dunn S.L., and White M.F. Phosphorylation of Irs1 at SER-522 inhibits insulin signaling. Mol. Endocrinol. 21 (2007) 2294-2302
55. Greene M.W., Sakaue H., Wang L., Alessi D.R., and Roth R.A. Modulation of insulin-stimulated degradation of human insulin receptor substrate-1 by Serine 312 phosphorylation. J. Biol. Chem. 278 (2003) 8199-8211
56. Greene M.W., Ruhoff M.S., Roth R.A., Kim J.A., Quon M.J., and Krause J.A. PKCdelta-mediated IRS-1 Ser24 phosphorylation negatively regulates IRS-1 function. Biochem. Biophys. Res. Commun. 349 (2006) 976-986
57. Griffin M.E., Marcucci M.J., Cline G.W., Bell K., Barucci N., Lee D., Goodyear L.J., Kraegen E.W., White M.F., and Shulman G.I. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 48 (1999) 1270-1274
58. Gual P., Gonzalez T., Gremeaux T., Barres R., Le M., Brustel Y., and Tanti J.F. Hyperosmotic stress inhibits IRS-1 function by distinct mechanisms in 3T3-L1 adipocytes. J. Biol. Chem. 278 (2003) 26550-26557
59. Guertin D.A., and Sabatini D.M. Defining the role of mTOR in cancer. Cancer Cell 12 (2007) 9-22
60. Gurevitch D., Boura-Halfon S., Issac R., Alberstein M., Ronen D., Lewis E., and Zick Y. Phosphorylation of selected serines at the PTB domain of IRS-2 regulates β cell growth, survival, and insulin secretion. Keystone Symposia on Islet and Beta Cell Development and Transplantation (2008 Abstract Book) (2008) 141
61. Gwinn D.M., Shackelford D.B., Egan D.F., Mihaylova M.M., Mery A., Vasquez D.S., Turk B.E., and Shaw R.J. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol. Cell 30 (2008) 214-226
62. Hardie D.G. AMPK and raptor: Matching cell growth to energy supply. Mol. Cell 30 (2008) 263-265
63. Harrington L.S., Findlay G.M., Gray A., Tolkacheva T., Wigfield S., Rebholz H., Barnett J., Leslie N.R., Cheng S., Shepherd P.R., Gout I., Downes C.P., et al. The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins. J. Cell Biol. 166 (2004) 213-223
64. Haruta T., Uno T., Kawahara J., Takano A., Egawa K., Sharma P.M., Olefsky J.M., and Kobayashi M. A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1. Mol. Endocrinol 14 (2000) 783-794
65. Hennige A.M., Stefan N., Kapp K., Lehmann R., Weigert C., Beck A., Moeschel K., Mushack J., Schleicher E., and Haring H.U. Leptin down-regulates insulin action through phosphorylation of serine-318 in insulin receptor substrate 1. FASEB J 20 (2006) 1206-1208
66. Henriksen E.J., and Dokken B.B. Role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes. Curr. Drug Targets 7 (2006) 1435-1441
67. Herschkovitz A., Liu Y.F., Ilan E., Ronen D., Boura-Halfon S., and Zick Y. Common inhibitory serine sites phosphorylated by IRS-1 kinases, triggered by insulin and inducers of insulin resistance. J. Biol. Chem. 282 (2007) 18018-18027
68. Hirabara S.M., Silveira L.R., Abdulkader F., Carvalho C.R., Procopio J., and Curi R. Time-dependent effects of fatty acids on skeletal muscle metabolism. J. Cell. Physiol. 210 (2007) 7-15
69. Hiratani K., Haruta T., Tani A., Kawahara J., Usui I., and Kobayashi M. Roles of mTOR and JNK in serine phosphorylation, translocation, and degradation of IRS-1. Biochem. Biophys. Res. Commun. 335 (2005) 836-842
70. Hirosumi J., Tuncman G., Chang L., Gorgun C.Z., Uysal K.T., Maeda K., Karin M., and Hotamisligil G.S. A central role for JNK in obesity and insulin resistance. Nature 420 (2002) 333-336
71. Horike N., Takemori H., Katoh Y., Doi J., Min L., Asano T., Sun X.J., Yamamoto H., Kasayama S., Muraoka M., Nonaka Y., and Okamoto M. Adipose-specific expression, phosphorylation of Ser794 in insulin receptor substrate-1, and activation in diabetic animals of salt-inducible kinase-2. J. Biol. Chem. 278 (2003) 18440-18447
72. Hotamisligil G.S., Shargill N.S., and Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin resistance. Science 259 (1993) 87-91
73. Hundal R.S., Petersen K.F., Mayerson A.B., Randhawa P.S., Inzucchi S., Shoelson S.E., and Shulman G.I. Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J. Clin. Invest. 109 (2002) 1321-1326
74. Inoki K., and Guan K.L. Complexity of the TOR signaling network. Trends Cell Biol. 16 (2006) 206-212
75. Inoki K., Corradetti M.N., and Guan K.L. Dysregulation of the TSC-mTOR pathway in human disease. Nat. Genet. 37 (2005) 19-24
76. Ishibashi K.I., Imamura T., Sharma P.M., Huang J., Ugi S., and Olefsky J.M. Chronic endothelin-1 treatment leads to heterologous desensitization of insulin signaling in 3T3-L1 adipocytes. J. Clin. Invest. 107 (2001) 1193-1202
77. Israel A. The IKK complex: An integrator of all signals that activate NF-kappaB?. Trends Cell Biol. 10 (2000) 129-133
78. Jakobsen S.N., Hardie D.G., Morrice N., and Tornqvist H.E. 5′-AMP-activated protein kinase phosphorylates IRS-1 on Ser-789 in mouse C2C12 myotubes in response to 5-aminoimidazole-4-carboxamide riboside. J. Biol. Chem. 276 (2001) 46912-46916
79. Kaburagi Y., Satoh S., Tamemoto H., Yamamoto H.R., Tobe K., Veki K., Yamauchi T., Kono S.E., Sekihara H., Aizawa S., Cushman S.W., Akanuma Y., et al. Role of insulin receptor substrate-1 and pp60 in the regulation of insulin-induced glucose transport and GLUT4 translocation in primary adipocytes. J. Biol. Chem. 272 (1997) 25839-25844
80. Kahn S.E., Hull R.L., and Utzschneider K.M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444 (2006) 840-846
81. Kanety H., Feinstein R., Papa M.Z., Hemi R., and Karasik A. Tumor necrosis factor alpha-induced phosphorylation of insulin receptor substrate-1 (IRS-1). Possible mechanism for suppression of insulin-stimulated tyrosine phosphorylation of IRS-1. J. Biol. Chem. 270 (1995) 23780-23784
82. Kanety H., Hemi R., Papa M.Z., and Karasik A. Sphingomyelinase and ceramide suppress insulin-induced tyrosine phosphorylation of the insulin receptor substrate-1. J. Biol. Chem. 271 (1996) 9895-9897
83. Karin M. The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation. J. Biol. Chem. 274 (1999) 27339-27342
84. Kawazoe Y., Naka T., Fujimoto M., Kohzaki H., Morita Y., Narazaki M., Okumura K., Saitoh H., Nakagawa R., Uchiyama Y., Akira S., and Kishimoto T. Signal transducer and activator of transcription (STAT)-induced STAT inhibitor 1 (SSI-1)/suppressor of cytokine signaling 1 (SOCS1) inhibits insulin signal transduction pathway through modulating insulin receptor substrate 1 (IRS-1) phosphorylation. J. Exp. Med. 193 (2001) 263-269
85. Kellerer M., Mushack J., Seffer E., Mischak H., Ullrich A., and Haring H.U. Protein kinase C isoforms alpha, delta and theta require insulin receptor substrate-1 to inhibit the tyrosine kinase activity of the insulin receptor in human kidney embryonic cells (HEK 293 cells). Diabetologia 41 (1998) 833-838
86. Khan A.H., and Pessin J.E. Insulin regulation of glucose uptake: A complex interplay of intracellular signalling pathways. Diabetologia 45 (2002) 1475-1483
87. Kim J.K., Kim Y.-J., Filmore J.J., Chen Y., Moore I., Lee J., Yuan M., Li Z.W., Karin M., Perrer P., Shoelson S., and Shulman G.I. Prevention of fat-induced insulin resistance by salicylate. J. Clin. Invest. 108 (2001) 437-446
88. Kim J.K., Fillmore J.J., Sunshine M.J., Albrecht B., Higashimori T., Kim D.W., Liu Z.X., Soos T.J., Cline G.W., O'Brien W.R., Littman D.R., and Shulman G.I. PKC-theta knockout mice are protected from fat-induced insulin resistance. J. Clin. Invest. 114 (2004) 823-827
89. Kim J.A., Yeh D.C., Ver M., Li Y., Carranza A., Conrads T.P., Veenstra T.D., Harrington M.A., and Quon M.J. Phosphorylation of Ser24 in the pleckstrin homology domain of insulin receptor substrate-1 by Mouse Pelle-like kinase/interleukin-1 receptor-associated kinase: Cross-talk between inflammatory signaling and insulin signaling that may contribute to insulin resistance. J. Biol. Chem. 280 (2005) 23173-23183
90. Krebs M., Brunmair B., Brehm A., Artwohl M., Szendroedi J., Nowotny P., Roth E., Furnsinn C., Promintzer M., Anderwald C., Bischof M., and Roden M. The Mammalian target of rapamycin pathway regulates nutrient-sensitive glucose uptake in man. Diabetes 56 (2007) 1600-1607
91. Kubota N., Kubota T., Itoh S., Kumagai H., Kozono H., Takamoto I., Mineyama T., Ogata H., Tokuyama K., Ohsugi M., Sasako T., Moroi M., et al. Dynamic functional relay between insulin receptor substrate 1 and 2 in hepatic insulin signaling during fasting and feeding. Cell Metab. 8 (2008) 49-64
92. Kulkarni R.N. Receptors for insulin and insulin-like growth factor-1 and insulin receptor substrate-1 mediate pathways that regulate islet function. Biochem. Soc. Trans. 30 (2002) 317-322
93. Lallena M.-J., Diaz-Meco M.T., Bren G., Paya C.V., and Moscat J. Activation of IkappaB kinase beta by protein kinase C isoforms. Mol. Cell. Biol. 19 (1999) 2180-2188
94. Lee Y.-H., Giraud J., Davis R.J., and White M.F. cJUN N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade. J. Biol. Chem. 278 (2003) 2896-2908
95. Lee Y.H., Giraud J., Davis R.J., and White M.F. c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade. J. Biol. Chem. 278 (2003) 2896-2902
96. Lee C.H., Inoki K., and Guan K.L. mTOR pathway as a target in tissue hypertrophy. Annu. Rev. Pharmacol. Toxicol 47 (2007) 443-467
97. Lee S., Lynn E.G., Kim J.A., and Quon M.J. Protein kinase C-ζ phosphorylates insulin receptor substrate-1, -3, and -4, but not -2: Isoform specific determinants of specificity in insulin signaling. Endocrinology 149 (2008) 2451-2458
98. Leitges M., Plomann M., Standaert M.L., Bandyopadhyay G., Sajan M.P., Kanoh Y., and Farese R.V. Knockout of PKC alpha enhances insulin signaling through PI3K. Mol. Endocrinol 16 (2002) 847-858
99. LeRoith D., and Zick Y. Recent advances in our understanding of insulin action and insulin resistance. Diabetes Care 24 (2001) 588-597
100. LeRoith D., Werner H., Beitner-Johnson D., and Roberts Jr. C.T. Molecular and cellular aspects of the insulin-like growth factor i receptor. Endocr. Rev. 16 (1995) 143-163
101. Li J., DeFea K., and Roth R.A. Modulation of insulin receptor substrate-1 tyrosine phosphorylation by an Akt/phosphatidylinositol 3-kinase pathway. J. Biol. Chem. 274 (1999) 9351-9356
102. Li Y., Soos T.J., Li X., Wu J., Degennaro M., Sun X., Littman D.R., Birnbaum M.J., and Polakiewicz R.D. Protein kinase C theta inhibits insulin signaling by phosphorylating IRS1 at Ser(1101). J. Biol. Chem. 279 (2004) 45304-45307
103. Li D., Yin X., Zmuda E.J., Wolford C.C., Dong X., White M.F., and Hai T. The repression of IRS2 gene by ATF3, a stress-inducible gene, contributes to pancreatic beta-cell apoptosis. Diabetes 57 (2008) 635-644
104. Li Y., Xu W., McBurney M.W., and Longo V.D. SirT1 inhibition reduces IGF-I/IRS-2/Ras/ERK1/2 signaling and protects neurons. Cell Metab. 8 (2008) 38-48
105. Liberman Z., and Eldar-Finkelman H. Serine 332 phosphorylation of insulin receptor substrate-1 by glycogen synthase kinase-3 attenuates insulin signaling. J. Biol. Chem. 280 (2005) 4422-4428
106. Liu Y.F., Paz K., Herschkovitz A., Alt A., Tennenbaum T., Sampson S.R., Ohba M., Kuroki T., LeRoith D., and Zick Y. Insulin stimulates PKCzeta-mediated phosphorylation of insulin receptor substrate-1 (IRS-1). A self-attenuated mechanism to negatively regulate the function of IRS proteins. J. Biol. Chem. 276 (2001) 14459-14465
107. Liu Y.F., Herschkovitz A., Boura H.S., Ronen D., Paz K., Leroith D., and Zick Y. Serine phosphorylation proximal to its phosphotyrosine binding domain inhibits insulin receptor substrate 1 function and promotes insulin resistance. Mol. Cell. Biol. 24 (2004) 9668-9681
108. Liu L.Z., Zhao H.L., Zuo J., Ho S.K., Chan J.C., Meng Y., Fang F.D., and Tong P.C. Protein kinase Czeta mediates insulin-induced glucose transport through actin remodeling in L6 muscle cells. Mol. Biol. Cell 17 (2006) 2322-2330
109. Lodhi I.J., Chiang S.H., Chang L., Vollenweider D., Watson R.T., Inoue M., Pessin J.E., and Saltiel A.R. Gapex-5, a Rab31 guanine nucleotide exchange factor that regulates Glut4 trafficking in adipocytes. Cell Metab. 5 (2007) 59-72
110. Luo M., Reyna S., Wang L., Yi Z., Carroll C., Dong L.Q., Langlais P., Weintraub S.T., and Mandarino L.J. Identification of insulin receptor substrate 1 serine/threonine phosphorylation sites using mass spectrometry analysis: Regulatory role of serine 1223. Endocrinology 146 (2005) 4410-4416
111. Luo M., Langlais P., Yi Z., Lefort N., De Filippis E.A., Hwang H., Christ-Roberts C.Y., and Mandarino L.J. Phosphorylation of human insulin receptor substrate-1 at serine 629 plays a positive role in insulin signaling. Endocrinology 148 (2007) 4895-4905
112. MacAulay K., Doble B.W., Patel S., Hansotia T., Sinclair E.M., Drucker D.J., Nagy A., and Woodgett J.R. Glycogen synthase kinase 3alpha-specific regulation of murine hepatic glycogen metabolism. Cell Metab. 6 (2007) 329-337
113. Manning B.D. Balancing Akt with S6K: Implications for both metabolic diseases and tumorigenesis. J. Cell Biol. 167 (2004) 399-403
114. McManus E.J., Sakamoto K., Armit L.J., Ronaldson L., Shpiro N., Marquez R., and Alessi D.R. Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis. EMBO J. 24 (2005) 1571-1583
115. Merforth S., Osmers A., and Dahlmann B. Alterations of proteasome activities in skeletal muscle tissue of diabetic rats. Mol. Biol. Rep. 26 (1999) 83-87
116. Moeschel K., Beck A., Weigert C., Lammers R., Kalbacher H., Voelter W., Schleicher E.D., Haring H.U., and Lehmann R. Protein kinase C-zeta-induced phosphorylation of Ser318 in receptor substrate-1 (IRS-1) attenuates the interaction with the receptor and the tyrosine phosphorylation of IRS-1. J. Biol. Chem. 279 (2004) 25157-25163
117. Mooney R.A., Senn J., Cameron S., Inamdar N., Boivin L.M., Shang Y., and Furlanetto R.W. Suppressors of cytokine signaling-1 and -6 associate with and inhibit the insulin receptor. A potential mechanism for cytokine-mediated insulin resistance. J. Biol. Chem. 276 (2001) 25889-25893
118. Morino K., Petersen K.F., and Shulman G.I. Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction. Diabetes 55 Suppl. 2 (2006) S9-S15
119. Morino K., Neschen S., Bilz S., Sono S., Tsirigotis D., Reznick R.M., Moore I., Nagai Y., Samuel V., Sebastian D., White M., Philbrick W., et al. Muscle specific IRS-1 Ser→Ala transgenic mice are protected from fat-induced insulin resistance in skeletal muscle. Diabetes 57 (2008) 2644-2651
120. Mothe I., and Van Obberghen E. Phosphorylation of insulin receptor substrate-1 on multiple serine residues, 612, 632, 662, and 731, modulates insulin action. J. Biol. Chem. 271 (1996) 11222-11227
121. Moxham C.M., Tabrizchi A., Davis R.J., and Malbon C.C. Jun N-terminal kinase mediates activation of skeletal muscle glycogen synthase by insulin in vivo. J. Biol. Chem. 271 (1996) 30765-30773
122. Muller G., Ayoub M., Storz P., Rennecke J., Fabbro D., and Pfizenmaier K. PKC zeta is a molecular switch in signal transduction of TNF-alpha, bifunctionally regulated by ceramide and arachidonic acid. EMBO J. 14 (1995) 1961-1969
123. Mussig K., Fiedler H., Staiger H., Weigert C., Lehmann R., Schleicher E.D., and Haring H.U. Insulin-induced stimulation of JNK and the PI 3-kinase/mTOR pathway leads to phosphorylation of serine 318 of IRS-1 in C2C12 myotubes. Biochem. Biophys. Res. Commun. 335 (2005) 819-825
124. Myers M.J., Sun K.J., and White M.F. The IRS-1 signaling system. Trends Biochem. Sci. 19 (1994) 289-293
125. Naka T., Tsutsui H., Fujimoto M., Kawazoe Y., Kohzaki H., Morita Y., Nakagawa R., Narazaki M., Adachi K., Yoshimoto T., Nakanishi K., and Kishimoto T. SOCS-1/SSI-1-deficient NKT cells participate in severe hepatitis through dysregulated cross-talk inhibition of IFN-gamma and IL-4 signaling in vivo. Immunity 14 (2001) 535-545
126. Nakajima K., Yamauchi K., Shigematsu S., Ikeo S., Komatsu M., Aizawa T., and Hashizume K. Selective attenuation of metabolic branch of insulin receptor down-signaling by high glucose in a hepatoma cell line, HepG2 cells. J. Biol. Chem. 275 (2000) 20880-20886
127. Nakamori Y., Emoto M., Fukuda N., Taguchi A., Okuya S., Tajiri M., Miyagishi M., Taira K., Wada Y., and Tanizawa Y. Myosin motor Myo1c and its receptor NEMO/IKK-gamma promote TNF-alpha-induced serine307 phosphorylation of IRS-1. J. Cell Biol. 173 (2006) 665-671
128. Nawaratne R., Gray A., Jorgensen C.H., Downes C.P., Siddle K., and Sethi J.K. Regulation of insulin receptor substrate 1 pleckstrin homology domain by protein kinase C: Role of serine 24 phosphorylation. Mol. Endocrinol 20 (2006) 1838-1852
129. Patti M.-E., Sun X.-J., Bruening J.C., Araki E., Lipes M.A., White M.F., and Kahn C.R. 4PS/insulin receptor substrate (IRS)-2 is the alternative substrate of the insulin receptor in IRS-1-deficient mice. J. Biol. Chem. 270 (1995) 24670-24673
130. Pawson T. Protein modules and signalling networks. Nature 373 (1995) 573-580
131. Paz K., Hemi R., LeRoith R., Karasik A., Elhanany E., Kanety H., and Zick Y. A Molecular basis for insulin resistance: Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. J. Biol. Chem. 272 (1997) 29911-29918
132. Paz K., Yan-Fang L., Shorer H., Hemi R., LeRoith D., Quon M., Kanety H., Seger R., and Zick Y. Phosphorylation of insulin receptor substrate-1 (IRS-1) by PKB positively regulates IRS-1 function. J. Biol. Chem. 274 (1999) 28816-28822
133. Pederson T.M., Kramer D.L., and Rondinone C.M. Serine/threonine phosphorylation of IRS-1 triggers its degradation: Possible regulation by tyrosine phosphorylation. Diabetes 50 (2001) 24-31
134. Pelosi L., Giacinti C., Nardis C., Borsellino G., Rizzuto E., Nicoletti C., Wannenes F., Battistini L., Rosenthal N., Molinaro M., and Musaro A. Local expression of IGF-1 accelerates muscle regeneration by rapidly modulating inflammatory cytokines and chemokines. FASEB J. 21 (2007) 1393-1402
135. Podcheko A., Northcott P., Bikopoulos G., Lee A., Bommareddi S.R., Kushner J.A., Farhang-Fallah J., and Rozakis-Adcock M. Identification of a WD40 repeat-containing isoform of PHIP as a novel regulator of beta-cell growth and survival. Mol. Cell. Biol. 27 (2007) 6484-6496
136. Qiao L.Y., Zhande R., Jetton T.L., Zhou G., and Sun X.J. In vivo phosphorylation of insulin receptor substrate 1 at serine 789 by a novel serine kinase in insulin-resistant rodents. J. Biol. Chem. 277 (2002) 26530-26539
137. Ravichandran L.V., Esposito D.L., Chen J., and Quon M.J. PKC-ζ phosphorylates IRS-1 and impairs its ability to activate PI 3-kinase in response to insulin. J. Biol. Chem. 276 (2001) 3543-3549
138. Ravichandran L.V., Esposito D.L., Chen J., and Quon M.J. Protein kinase C-zeta phosphorylates insulin receptor substrate-1 and impairs its ability to activate phosphatidylinositol 3-kinase in response to insulin. J. Biol. Chem. 276 (2001) 3543-3549
139. Ribon V., and Saltiel A.R. Insulin stimulates tyrosine phosphorylation of the proto-oncogene product of c-Cbl in 3T3-L1 adipocytes. Biochem. J. 324 Pt. 3 (1997) 839-845
140. Robinson M.J., Sancho D., Slack E.C., LeibundGut-Landmann S., and Reis e Sousa C. Myeloid C-type lectins in innate immunity. Nat. Immunol. 7 (2006) 1258-1265
141. Rui L., Yuan M., Frantz D., Shoelson S., and White M.F. SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J. Biol. Chem. 277 (2002) 42394-42398
142. Salih D.A., and Brunet A. FoxO transcription factors in the maintenance of cellular homeostasis during aging. Curr. Opin. Cell Biol. 20 (2008) 126-136
143. Saltiel A.R., and Kahn C.R. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414 (2001) 799-806
144. Saltiel A.R., and Pessin J.E. Insulin signaling pathways in time and space. Trends Cell Biol. 12 (2002) 65-71
145. Sampson S.R., and Cooper D.R. Specific protein kinase C isoforms as transducers and modulators of insulin signaling. Mol. Genet. Metab. 89 (2006) 32-47
146. Sancak Y., Thoreen C.C., Peterson T.R., Lindquist R.A., Kang S.A., Spooner E., Carr S.A., and Sabatini D.M. PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Mol. Cell 25 (2007) 903-915
147. Sancak Y., Peterson T.R., Shaul Y.D., Lindquist R.A., Thoreen C.C., Bar-Peled L., and Sabatini D.M. The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 320 (2008) 1496-1501
148. Sanz L., Sanchez P., Lallena M.J., Diaz M.M., and Moscat J. The interaction of p62 with RIP links the atypical PKCs to NF-kappaB activation. EMBO J. 18 (1999) 3044-3053
149. Sawka V.D., Tartare D.S., White M.F., and Van O.E. Insulin receptor substrate-2 binds to the insulin receptor through its phosphotyrosine-binding domain and through a newly identified domain comprising amino acids 591-786. J. Biol. Chem. 271 (1996) 5980-5983
150. Sawka-Verhelle D., Baron V., Mothe I., Filloux C., White M.F., and Van Obberghen E. Tyr624 and Tyr628 in insulin receptor substrate-2 mediate its association with the insulin receptor. J. Biol. Chem. 272 (1997) 16414-16420
151. Schmitz-Peiffer C., Browne C.L., Oakes N.D., Watkinson A., Chisholm D.J., Kraegen E.W., and Biden T.J. Alterations in the expression and cellular localization of protein kinase C isozymes epsilon and theta are associated with insulin resistance in skeletal muscle of the high-fat-fed rat. Diabetes 46 (1997) 169-178
152. Seely B.L., Reichart D.R., Staubs P.A., Jhun B.H., Hsu D., Maegawa H., Milarski K.L., Saltiel A.R., and Olefsky J.M. Localization of the insulin-like growth factor I receptor binding sites for the SH2 domain proteins p85, Syp, and GTPase activating protein. J. Biol. Chem. 270 (1995) 19151-19157
153. Serra C., Federici M., Buongiorno A., Senni M.I., Morelli S., Segratella E., Pascuccio M., Tiveron C., Mattei E., Tatangelo L., Lauro R., Molinaro M., et al. Transgenic mice with dominant negative PKC-theta in skeletal muscle: A new model of insulin resistance and obesity. J. Cell. Physiol. 196 (2003) 89-97
154. Sesti G., Federici M., Hribal M.L., Lauro D., Sbraccia P., and Lauro R. Defects of the insulin receptor substrate (IRS) system in human metabolic disorders. FASEB J. 15 (2001) 2099-2111
155. Shah O.J., Wang Z., and Hunter T. Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies. Curr. Biol. 14 (2004) 1650-1656
156. Sharfi H., and Eldar-Finkelman H. Sequential phosphorylation of insulin receptor substrate-2 by glycogen synthase kinase-3 and c-Jun NH2-terminal kinase plays a role in hepatic insulin signaling. Am. J. Physiol. Endocrinol. Metab. 294 (2007) E307-E315
157. Shargill N.S., Tatoyan A., el-Refai M., Pleta M., and Chan T.M. Impaired insulin receptor phosphorylation in skeletal muscle membranes of db/db mice: The use of a novel skeletal muscle plasma membrane preparation to compare insulin binding and stimulation of receptor phosphorylation. Biochem. Biophys. Res. Commun. 137 (1986) 286-294
158. Shoelson S.E., Lee J., and Goldfine A.B. Inflammation and insulin resistance. J. Clin. Invest. 116 (2006) 1793-1801
159. Smith L.K., Vlahos C.J., Reddy K.K., Falck J.R., and Garner C.W. Wortmannin and LY294002 inhibit the insulin-induced down-regulation of IRS-1 in 3T3-L1 adipocytes. Mol. Cell. Endocrinol. 113 (1995) 73-81
160. Solinas G., Naugler W., Galimi F., Lee M.S., and Karin M. Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substrates. Proc. Natl. Acad. Sci. USA 103 (2006) 16454-16459
161. Sommerfeld M.R., Metzger S., Stosik M., Tennagels N., and Eckel J. In vitro phosphorylation of insulin receptor substrate 1 by protein kinase C-zeta: Functional analysis and identification of novel phosphorylation sites. Biochemistry 43 (2004) 5888-5901
162. Standaert M.L., Galloway L., Karnam P., Bandyopadhyay G., Moscat J., and Farese R.V. Protein kinase C-zeta as a downstream effector of phosphatidylinositol 3-kinase during insulin stimulation in rat adipocytes. Potential role in glucose transport. J. Biol. Chem. 272 (1997) 30075-30082
163. Sun X.J., Rothenberg P., Kahn C.R., Backer J.M., Araki E., Wilden P.A., Cahill D.A., Goldstein B.J., and White M.F. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 352 (1991) 73-77
164. Sun X.J., Wang L.M., Zhang Y., Yenush L., Myers Jr. M.G., Glasheen E., Lane W.S., Pierce J.H., and White M.F. Role of IRS-2 in insulin and cytokine signalling. Nature 377 (1995) 173-177
165. Sun X.J., Goldberg J.L., Qiao L.Y., and Mitchell J.J. Insulin-induced insulin receptor substrate-1 degradation is mediated by the proteasome degradation pathway. Diabetes 48 (1999) 1359-1364
166. Sun Z., Arendt C.W., Ellmeier W., Schaeffer E.M., Sunshine M.J., Gandhi L., Annes J., Petrzilka D., Kupfer A., Schwartzberg P.L., and Littman D.R. PKC-theta is required for TCR-induced NF-kappaB activation in mature but not immature T lymphocytes. Nature 404 (2000) 402-407
167. Tamemoto H., Kadowaki T., Tobe K., Yagi T., Sakura H., Hayakawa T., Terauchi Y., Ueki K., Kaburagi Y., Satoh S., Sekihara H., Yoshioka S., et al. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372 (1994) 182-186
168. Taniguchi C.M., Emanuelli B., and Kahn C.R. Critical nodes in signalling pathways: Insights into insulin action. Nat. Rev. Mol. Cell Biol. 7 (2006) 85-96
169. Tirosh A., Potashnik R., Bashan N., and Rudich A. Oxidative stress disrupts insulin-induced cellular redistribution of insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-L1 adipocytes. A putative cellular mechanism for impaired protein kinase B activation and GLUT4 translocation. J. Biol. Chem. 274 (1999) 10595-10602
170. Tremblay F., Brule S., Hee Um S., Li Y., Masuda K., Roden M., Sun X.J., Krebs M., Polakiewicz R.D., Thomas G., and Marette A. Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance. Proc. Natl. Acad. Sci. USA 104 (2007) 14056-14061
171. Tyers M., and Willems A.R. One ring to rule a superfamily of E3 ubiquitin ligases. Science 284 (1999) 603-604
172. Tzatsos A., and Tsichlis P.N. Energy depletion inhibits phosphatidylinositol 3-kinase/Akt signaling and induces apoptosis via AMP-activated protein kinase-dependent phosphorylation of IRS-1 at Ser-794. J. Biol. Chem. 282 (2007) 18069-18082
173. Ullrich A., Bell J.R., Chen E.Y., Herrera R., Petruzelli L.M., Dull T.J., Gray A., Coussens L., Liao Y.C., Tsubokawa M., Mason A., Seeburg P.H., et al. Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature 313 (1985) 756-761
174. Ullrich A., Gray A., Tam A., Yang-Feng W.T., Tsubokawa M., Collins C., Henzel W., Le Bon T., Kathuria S., Chen E., Jacobs S., Francke U., et al. Insulin-like growth factor I receptor primary structure: Comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J. 5 (1986) 2503-2512
175. Um S.H., Frigerio F., Watanabe M., Picard F., Joaquin M., Sticker M., Fumagalli S., Allegrini P.R., Kozma S.C., Auwerx J., and Thomas G. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 431 (2004) 200-205
176. Um S.H., D'Alessio D., and Thomas G. Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. Cell Metab. 3 (2006) 393-402
177. Usui I., Imamura T., Babendure J.L., Satoh H., Lu J.C., Hupfeld C.J., and Olefsky J.M. G protein-coupled receptor kinase 2 mediates endothelin-1-induced insulin resistance via the inhibition of both Galphaq/11 and insulin receptor substrate-1 pathways in 3T3-L1 adipocytes. Mol. Endocrinol 19 (2005) 2760-2768
178. Venters H.D., Tang Q., Liu Q., VanHoy R.W., Dantzer R., and Kelley K.W. A new mechanism of neurodegeneration: A proinflammatory cytokine inhibits receptor signaling by a survival peptide. Proc. Natl. Acad. Sci. USA 96 (1999) 9879-9884
179. Voliovitch H., Schindler D.G., Hadari Y.R., Taylor S.I., Accili D., and Zick Y. Tyrosine phosphorylation of insulin receptor substrate-1 in vivo depends upon the presence of its pleckstrin homology region. J. Biol. Chem. 270 (1995) 18083-18087
180. Wang Q., Somwar R., Bilan P.J., Liu Z., Jin J., Woodgett J.R., and Klip A. Protein kinase B/Akt participates in GLUT4 translocation by insulin in L6 myoblasts. Mol. Cell. Biol. 19 (1999) 4008-4018
181. Wellen K.E., and Hotamisligil G.S. Inflammation, stress, and diabetes. J. Clin. Invest. 115 (2005) 1111-1119
182. White M.F. IRS proteins and the common path to diabetes. Am. J. Physiol. Endocrinol. Metab. 283 (2002) E413-E422
183. Withers D.J., Gutierrez J.S., Towery H., Burks D.J., Ren J.M., Previs S., Zhang Y., Bernal D., Pons S., Shulman G.I., Bonner W.S., and White M.F. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391 (1998) 900-904
184. Withers D.J., Burks D.J., Towery H.H., Altamuro S.L., Flint C.L., and White M.F. Irs-2 coordinates Igf-1 receptor-mediated beta-cell development and peripheral insulin signalling. Nat. Genet. 23 (1999) 32-40
185. Wolf G., Trüb T., Ottinger E., Groninga L., Lynch A., White M.F., Miyazaki M., Lee J., and Shoelson S.E. PTB domains of IRS-1 and Shc have distinct but overlapping binding specificities. J. Biol. Chem. 270 (1995) 27407-27410
186. Wu J., Tseng Y.D., Xu C.F., Neubert T.A., White M.F., and Hubbard S.R. Structural and biochemical characterization of the KRLB region in insulin receptor substrate-2. Nat. Struct. Mol. Biol. 15 (2008) 251-258
187. Wullschleger S., Loewith R., and Hall M.N. TOR signaling in growth and metabolism. Cell 124 (2006) 471-484
188. Yamauchi T., Tobe K., Tamemoto H., Ueki K., Kaburagi Y., Yamamoto H.R., Takahashi Y., Yoshizawa F., Aizawa S., Akanuma Y., Sonenberg N., Yazaki Y., et al. Insulin signalling and insulin actions in the muscles and livers of insulin-resistant, insulin receptor substrate 1-deficient mice. Mol. Cell. Biol. 16 (1996) 3074-3084
189. Yang Q., and Guan K.L. Expanding mTOR signaling. Cell Res. 17 (2007) 666-681
190. Yasukawa H., Sasaki A., and Yoshimura A. Negative regulation of cytokine signaling pathways. Annu. Rev. Immunol. 18 (2000) 143-164
191. Yi Z., Langlais P., De Filippis E.A., Luo M., Flynn C.R., Schroeder S., Weintraub S.T., Mapes R., and Mandarino L.J. Global assessment of regulation of phosphorylation of insulin receptor substrate-1 by insulin in vivo in human muscle. Diabetes 56 (2007) 1508-1516
192. Youngren J.F. Regulation of insulin receptor function. Cell. Mol. Life Sci. 64 (2007) 873-891
193. Yu C., Chen Y., Cline G.W., Zhang D., Zong H., Wang Y., Bergeron R., Kim J.K., Cushman S.W., Cooney G.J., Atcheson B., White M.F., et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J. Biol. Chem. 277 (2002) 50230-50236
194. Yu C., Chen Y., Zong H., Wang Y., Bergeron R., Kim J.K., Cline G.W., Cushman S.W., Cooney G.J., Atcheson B., White M.F., Kraegen E.W., et al. Mechanism by which fatty acids inhibit insulin activation of IRS-1 associated phosphatidylinositol 3-kinase activity in muscle. J. Biol. Chem. 277 (2002) 50230-50236
195. Yuan M., Konstantopoulos N., Lee J., Hansen L., Li Z.-W., Karin M., and Shoelson S.E. Reversal of obesity and diet induced insulin resistance with salicylates or targeted disruption of IKK beta. Science 293 (2001) 1673-1677
196. Zhande R., Mitchell J.J., Wu J., and Sun X.J. Molecular mechanism of insulin-induced degradation of insulin receptor substrate 1. Mol. Cell. Biol. 22 (2002) 1016-1026
197. Zhang J. The direct involvement of SirT1 in insulin-induced insulin receptor substrate-2 tyrosine phosphorylation. J. Biol. Chem. 282 (2007) 34356-34364
198. Zhou B.P., Liao Y., Xia W., Zou Y., Spohn B., and Hung M.C. HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation. Nat. Cell Biol. 3 (2001) 973-982
199. Zick Y. Insulin resistance: A phosphorylation-based uncoupling of insulin signaling. Trends Cell Biol. 11 (2001) 437-441
200. Zick Y. Role of Ser/Thr kinases in the uncoupling of insulin signaling. Int. J. Obes. Relat. Metab. Disord. 27 Suppl. 3 (2003) S56-S60
201. Zick Y. Uncoupling insulin signalling by serine/threonine phosphorylation: A molecular basis for insulin resistance. Biochem. Soc. Trans. 32 (2004) 812-816
202. Zick Y. Ser/Thr phosphorylation of IRS proteins: A molecular basis for insulin resistance. Sci. STKE 2005. (2005) pe4